# Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia

> **NCT06979141** · PHASE3 · RECRUITING · sponsor: **Al-Azhar University** · enrollment: 300 (estimated)

## Conditions studied

- Cough

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Magnesium sulfate
- **DRUG:** Lidocaine
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT06979141
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979141, "Dexmedetomidine, Magnesium Sulphate and Lidocaine for Cough Suppression After General Anesthesia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06979141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*